NewAmsterdam Pharma Correlations

NAMS Stock

23.87 0.20 0.83%

The current 90-days correlation between NewAmsterdam Pharma and Monte Rosa Therapeutics is 0.3 (i.e., Weak diversification). The correlation of NewAmsterdam Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

NewAmsterdam Pharma Correlation With Market

Good diversification

The correlation between NewAmsterdam Pharma and DJI is -0.1 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NewAmsterdam Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For more information on how to buy NewAmsterdam Stock please use our How to Invest in NewAmsterdam Pharma guide.

Moving together with NewAmsterdam Stock

0.61	CDIO	Cardio Diagnostics	Pair Corr
0.7	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.81	MRK	Merck Company	Pair Corr

Moving against NewAmsterdam Stock

0.82	GE	GE Aerospace	Pair Corr
0.77	WM	Waste Management	Pair Corr
0.74	PLX	Protalix Biotherapeutics	Pair Corr
0.65	WMT	Walmart	Pair Corr
0.64	LUCD	Lucid Diagnostics	Pair Corr
0.44	MLSS	Milestone Scientific Earnings Call This Week	Pair Corr
0.38	ABUS	Arbutus Biopharma Corp	Pair Corr
0.34	PG	Procter Gamble	Pair Corr
0.81	CSCO	Cisco Systems	Pair Corr
0.77	IBM	International Business	Pair Corr
0.76	JPM	JPMorgan Chase	Pair Corr
0.72	MMM	3M Company	Pair Corr
0.63	T	ATT Inc Earnings Call Today	Pair Corr
0.63	DD	Dupont De Nemours	Pair Corr
0.56	JNJ	Johnson Johnson	Pair Corr
0.52	CVX	Chevron Corp	Pair Corr
0.46	INTC	Intel	Pair Corr
0.34	XOM	Exxon Mobil Corp	Pair Corr
0.33	BA	Boeing	Pair Corr

Related Correlations Analysis

	GLUE	IVA	CGEM	CMPX	REPL	CRNX	PRTC	MRUS	MLYS
GLUE		-0.22	0.51	-0.41	0.12	0.65	0.63	0.01	0.43	GLUE
IVA	-0.22		-0.84	0.36	0.06	-0.62	-0.36	0.8	0.18	IVA
CGEM	0.51	-0.84		-0.58	0.02	0.88	0.53	-0.56	0.04	CGEM
CMPX	-0.41	0.36	-0.58		0.58	-0.77	-0.33	-0.08	-0.5	CMPX
REPL	0.12	0.06	0.02	0.58		-0.08	0.26	-0.18	-0.41	REPL
CRNX	0.65	-0.62	0.88	-0.77	-0.08		0.69	-0.28	0.22	CRNX
PRTC	0.63	-0.36	0.53	-0.33	0.26	0.69		-0.3	-0.11	PRTC
MRUS	0.01	0.8	-0.56	-0.08	-0.18	-0.28	-0.3		0.48	MRUS
MLYS	0.43	0.18	0.04	-0.5	-0.41	0.22	-0.11	0.48		MLYS
	GLUE	IVA	CGEM	CMPX	REPL	CRNX	PRTC	MRUS	MLYS

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CRNX	+ 0.88	CGEM
MRUS	+ 0.8	IVA
PRTC	+ 0.69	CRNX
CRNX	+ 0.65	GLUE
PRTC	+ 0.63	GLUE
REPL	+ 0.58	CMPX

High negative correlations

CGEM	- 0.84	IVA
CRNX	- 0.77	CMPX
CRNX	- 0.62	IVA
CMPX	- 0.58	CGEM
MRUS	- 0.56	CGEM
MLYS	- 0.5	CMPX

Risk-Adjusted Indicators

There is a big difference between NewAmsterdam Stock performing well and NewAmsterdam Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze NewAmsterdam Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
GLUE	3.56	(0.22)	0.00	(0.26)	0.00	0.00	7.34	(7.69)	19.92
IVA	2.97	0.35	0.09	0.29	3.36	(3.46)	5.84	(5.73)	23.67
CGEM	2.58	(0.40)	0.00	(0.73)	0.00	0.00	5.13	(6.43)	15.27
CMPX	5.34	1.16	0.19	0.31	5.04	(6.81)	14.18	(8.88)	44.59
REPL	2.83	(0.06)	0.00	(0.11)	0.00	0.00	5.86	(5.88)	22.75
CRNX	2.52	(0.56)	0.00	(0.71)	0.00	0.00	3.33	(6.70)	19.41
PRTC	2.00	(0.28)	0.00	1.28	0.00	0.00	3.79	(5.77)	15.36
MRUS	1.94	0.16	0.09	(0.74)	2.44	(2.12)	4.91	(3.56)	12.66
MLYS	4.29	0.63	0.17	(0.45)	4.26	(4.97)	10.04	(8.23)	50.53

NewAmsterdam Pharma Corporate Management

Louise Kooij	Treasurer, CFO	Profile
Jim Jacobson	Chief Secretary	Profile
Annie Neild	VP Affairs	Profile
FESC MD	Chief Founder	Profile
Marc MD	Chief Officer	Profile
MSc MBA	Chief Officer	Profile
Lina Gugucheva	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC